International Journal of Phytomedicine and Phytotherapy
Treatment groups | Serum biomarkers of hepatic injuries | |||||
---|---|---|---|---|---|---|
T-Protein (g/dL) | Albumin (g/dL) | ALT (U/L) | AST (U/L) | ALP (U/L) | T-Bilirubin (mg/dL) | |
I. Normal control | 6.68 ± 0.69 | 3.00 ± 0.13 | 30.12 ± 3.46 | 27.56 ± 5.17 | 22.32 ± 6.59 | 0.62 ± 0.12 |
II. 5 mg/kg Cisplatin | 6.42 ± 0.70 | 3.50 ± 0.32 | 178.0 ± 38.5a | 73.44 ± 2.75a | 48.04 ± 3.09a | 3.78 ± 1.15a |
III. 200 mg/kg LLE | 6.48 ± 0.41 | 3.12 ± 0.26 | 33.72 ± 5.98b | 37.14 ± 9.58b | 35.32 ± 5.87 | 0.56 ± 0.09b |
IV. 400 mg/kg LLE | 5.56 ± 0.37 | 2.98 ± 0.16 | 31.50 ± 2.83b | 30.22 ± 3.26b | 39.36 ± 10.1 | 0.48 ± 0.17b |
V. 200 mg/kg LLE + CIS | 7.28 ± 0.88 | 3.12 ± 0.16 | 44.08 ± 8.18b | 42.56 ± 4.49b | 34.60 ± 6.28 | 0.40 ± 0.14b |
VI. 400 mg/kg LLE + CIS | 6.24 ± 0.42 | 2.90 ± 0.20 | 66.40 ± 6.65b | 34.16 ± 2.82b | 34.40 ± 5.36 | 1.86 ± 0.10b |